IRIS
MACCARI, Rosanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.876
NA - Nord America 5.520
AS - Asia 2.694
SA - Sud America 908
Continente sconosciuto - Info sul continente non disponibili 88
AF - Africa 65
OC - Oceania 6
Totale 15.157
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.432
RU - Federazione Russa 2.967
SG - Singapore 1.151
CN - Cina 794
BR - Brasile 788
IE - Irlanda 760
SE - Svezia 687
UA - Ucraina 338
HK - Hong Kong 319
DE - Germania 310
IT - Italia 205
FI - Finlandia 149
GB - Regno Unito 138
FR - Francia 137
VN - Vietnam 107
IN - India 77
PL - Polonia 72
BD - Bangladesh 37
AR - Argentina 36
CA - Canada 35
MX - Messico 28
IQ - Iraq 27
AT - Austria 24
TR - Turchia 22
PK - Pakistan 21
MA - Marocco 19
UZ - Uzbekistan 19
EC - Ecuador 17
BE - Belgio 16
VE - Venezuela 16
NL - Olanda 15
CO - Colombia 14
JP - Giappone 14
KE - Kenya 12
ZA - Sudafrica 12
ID - Indonesia 11
CL - Cile 10
ES - Italia 10
IR - Iran 10
MY - Malesia 9
CR - Costa Rica 8
PE - Perù 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
LT - Lituania 7
NP - Nepal 7
PY - Paraguay 7
AU - Australia 6
BO - Bolivia 6
IL - Israele 6
JM - Giamaica 6
PH - Filippine 6
EG - Egitto 5
JO - Giordania 5
KR - Corea 5
OM - Oman 5
PT - Portogallo 5
RS - Serbia 5
TN - Tunisia 5
UY - Uruguay 5
AZ - Azerbaigian 4
LB - Libano 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
DZ - Algeria 3
ET - Etiopia 3
GT - Guatemala 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LV - Lettonia 3
NO - Norvegia 3
RO - Romania 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BN - Brunei Darussalam 2
CG - Congo 2
CH - Svizzera 2
EE - Estonia 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
KW - Kuwait 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BT - Bhutan 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
MD - Moldavia 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
Totale 15.066
Salva come PNG Salva come JPEG
Città #
Moscow 893
Dublin 760
Ashburn 656
Jacksonville 618
Singapore 606
Chandler 600
Dallas 524
Nyköping 437
Dearborn 390
Hong Kong 318
Beijing 303
San Jose 255
Council Bluffs 174
The Dalles 127
Princeton 120
Medford 116
Los Angeles 114
Cambridge 110
Lauterbourg 99
Ann Arbor 81
Boardman 79
Munich 79
Des Moines 72
Warsaw 67
Buffalo 63
New York 60
Messina 57
São Paulo 52
Ho Chi Minh City 50
Tianjin 39
San Mateo 34
Woodbridge 33
Guangzhou 31
Turku 31
Jinan 30
Wilmington 28
Columbus 27
Lancaster 23
Orem 23
Santa Clara 23
Belo Horizonte 22
Vienna 21
Phoenix 20
Chennai 19
Denver 19
Rio de Janeiro 19
Seattle 19
Frankfurt am Main 18
Redondo Beach 17
Brussels 16
Houston 16
Haikou 15
Tashkent 15
Hanoi 14
Atlanta 13
Brasília 13
Chicago 13
Nanjing 13
Stockholm 13
Curitiba 12
Salvador 12
Shanghai 12
Shenyang 12
Tokyo 12
Washington 12
Boston 11
Hefei 11
London 11
Montreal 11
Shenzhen 11
Taizhou 11
Baghdad 10
Düsseldorf 10
Francofonte 10
Hebei 10
Johannesburg 10
Manchester 10
Milan 10
Mumbai 10
San Francisco 10
Taiyuan 10
Campinas 9
Nairobi 9
Pune 9
Sorocaba 9
Ardabil 8
Brooklyn 8
Fuzhou 8
Helsinki 8
Mexico City 8
Nanchang 8
San José 8
Amsterdam 7
Changsha 7
Contagem 7
Dhaka 7
Ankara 6
Auburn Hills 6
Charlotte 6
Fortaleza 6
Totale 8.899
Salva come PNG Salva come JPEG
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 253
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 210
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 191
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 189
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 188
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 186
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 185
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 179
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 178
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 177
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 176
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 175
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 173
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 171
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 171
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 170
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 168
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 168
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 167
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 166
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 163
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 163
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 162
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 162
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 160
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 160
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 159
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 159
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 153
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 153
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 152
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 150
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 150
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 150
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 149
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 147
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 147
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 147
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 145
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 144
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 142
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 142
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 141
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 140
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 139
Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells 139
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 135
(5-Arylidene-2-thioxo-4-oxothiazolidin-3-yl)acetic acids endowed with chondroprotective and matrix metalloproteinase inhibitory activities 134
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 133
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 129
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 129
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 128
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 128
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 126
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 126
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 125
EVALUATION OF 4-THIAZOLIDINONE DERIVATIVES AS ALPHA-AMYLASE INHIBITORS 125
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 123
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 122
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 122
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 122
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 121
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 119
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 119
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 118
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 118
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 117
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 116
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 116
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 115
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 111
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 111
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 111
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 110
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 110
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 109
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 109
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 107
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 107
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 107
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 106
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 106
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 105
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 105
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 105
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 103
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 103
HALOGENATED ISONIAZID DERIVATIVES .4. 1-METHYLIDENEAMINO-2- TRIFLUOROMETHYLAZIRIDINES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 103
Protein-tyrosine phosphatase-1B mediates sleep fragmentation-induced insulin resistance and visceral adipose tissue inflammation in mice 103
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 102
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 100
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 100
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 100
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 99
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 98
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 96
Sintesi, attività in vitro e SARs di 2,4-tiazolidindioni inibitori dell'aldoso reduttasi 93
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell’aldoso reduttasi. 93
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 92
Isonicotinoilidrazoni fluorurati: reattività ed attività antimicobatterica ed anti-HIV 91
Totale 13.620
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022694 0 100 13 22 43 5 57 24 10 33 125 262
2022/20232.254 161 236 102 217 166 235 63 101 902 10 52 9
2023/2024395 32 78 49 35 46 80 6 20 0 13 2 34
2024/20252.140 21 21 41 135 82 38 57 445 578 128 188 406
2025/20266.734 304 501 483 477 513 1.542 820 841 785 243 127 98
2026/2027280 82 198 0 0 0 0 0 0 0 0 0 0
Totale 15.157